Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04040452 · ClinicalTrials.gov registry record · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
A Phase 4 study of Congenital Heart Disease in Children, sponsored by Phoenix Children's Hospital.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 166
- Enrollment target
- 1
- Study location
NCT04040452: Recruiting Phase 4 study of Congenital Heart Disease in Children, sponsored by Phoenix Children's Hospital.
NCT04040452 is a Phase 4 study of Congenital Heart Disease in Children that is actively recruiting participants, run by Phoenix Children's Hospital. The registered enrollment target is 166 participants, below the 1,990-participant average among 6 other Congenital Heart Disease in Children trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04040452, a Phase 4 study of Congenital Heart Disease in Children, is actively recruiting participants, sponsored by Phoenix Children's Hospital.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 166 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed study will be a prospective, randomized, double blind, placebo controlled trial to compare the use of a continuous infusion versus intermittent ketorolac on postoperative patients in the pediatric cardiovascular ICU. We intend to determine if the continuous infusion leads to a decreased utilization of opiates when compared to intermittent ketorolac.
Primary Outcome
The total opioid receipt (converted to fentanyl equivalents) administered to patients enrolled in the study within the first 96 hours after cardiac surgery.
Conditions Studied
Interventions
- DRUG Continuous ketorolac
Study Locations (1)
Arizona
- Phoenix Children's Hospital - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2026-12-01 |
| Phase | Phase 4 |
What NCT04040452 shows while recruiting
NCT04040452 is an interventional study that assigns participants to a tested intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap, below the 1,990-participant average among 6 other Congenital Heart Disease in Children trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Congenital Heart Disease in Children appearing as the primary indexed condition, and to 1 intervention - of which Continuous ketorolac is the first listed.
NCT04040452 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT04040452 about?
NCT04040452 is a clinical study titled "Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery". The proposed study will be a prospective, randomized, double blind, placebo controlled trial to compare the use of a continuous infusion versus intermittent ketorolac on postoperative patients in the pediatric cardiovascular ICU. We intend to determine if the continuous infusion leads to a decreased...
What is the current status of trial NCT04040452?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 166 participants. The study started on 2021-03-01. Estimated completion is 2026-12-01.
What conditions does trial NCT04040452 study?
This clinical trial studies the following conditions: Congenital Heart Disease in Children.
What interventions are being tested in trial NCT04040452?
The interventions under investigation include: Continuous ketorolac (DRUG).
Who is sponsoring clinical trial NCT04040452?
This trial is sponsored by Phoenix Children's Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04040452 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease in Children
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Remote Cardiac Rehab for Adolescents With Congenital Heart Disease
RECRUITING · NA
-
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
RECRUITING · Phase 2
-
Evaluating Pulse Oximetry Bias in Children With Darker Skin Pigmentation
RECRUITING
-
Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac Procedures
RECRUITING
-
Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)
ACTIVE NOT RECRUITING · NA
-
STeroids to REduce Systemic Inflammation After Infant Heart Surgery
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
- NCT04501406 · 166 participants · Phase 2
Low-Dose Pioglitazone in Patients With NASH (AIM 2)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI